Board Meeting18 May 2026, 02:42 pm
Lincoln Pharma Board Meeting on May 28, 2026 for Results & Dividend
AI Summary
Lincoln Pharmaceuticals Ltd has scheduled a Board of Directors meeting on May 28, 2026, to consider and approve the audited financial results for the quarter and year ended March 31, 2026. The board will also consider the recommendation of a dividend on equity shares, if any. The trading window, which has been closed since April 1, 2026, will reopen 48 hours after the results are made public.
Key Highlights
- Board meeting scheduled for May 28, 2026.
- Agenda includes approval of audited financial results.
- Dividend recommendation to be considered.
- Trading window to reopen 48 hours post result announcement.
Price Impact
More from LINCOPH